[Congressional Record Volume 167, Number 42 (Friday, March 5, 2021)]
[Senate]
[Page S1361]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1299. Mr. BURR submitted an amendment intended to be proposed to 
amendment SA 891 proposed by Mr. Schumer (for himself, Mr. Wyden, Mrs. 
Murray, Mr. Brown, Mr. Peters, Mr. Cardin, Ms. Cantwell, Ms. Stabenow, 
Mr. Tester, Mr. Menendez, Mr. Schatz, Mr. Carper, Mr. Leahy, and Mr. 
Sanders) to the bill H.R. 1319, to provide for reconciliation pursuant 
to title II of S. Con. Res. 5; which was ordered to lie on the table; 
as follows:
        On page 84, line 9, strike ``to be'' and all that follows 
     through ``COVID-19'' on line 19, page 84 and insert the 
     following:
     to prevent, prepare for, and respond to COVID-19, 
     domestically or internationally, including the development 
     and review of medical countermeasures to address COVID-19 and 
     emerging variants of COVID-19, and which may be used for the 
     evaluation of the continued performance, safety, and 
     effectiveness, including with respect to emerging COVID-19 
     variants, of vaccines, therapeutics, and diagnostics 
     approved, cleared, licensed, or authorized for use for the 
     treatment, prevention, or diagnosis of COVID-19; facilitation 
     of advanced continuous manufacturing activities related to 
     production of vaccines and related materials; facilitation 
     and conduct of inspections related to the manufacturing of 
     vaccines, therapeutics, and devices delayed or cancelled for 
     reasons related to COVID-19, including modernizing inspection 
     processes; facilitation of the use of real world evidence and 
     real world data for approved, cleared, licensed, or 
     authorized medical products.
                                 ______